ArticleBiomedical optics express2012
Seeing it through: translational validation of new medical imaging modalities.
Article in Biomedical optics express, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Exploiting Nanomaterials for Optical Coherence Tomography and Photoacoustic Imaging in Nanodentistry.Nanomaterials (Basel, Switzerland) · 2022Review
- Suite of 3D test objects for performance assessment of hybrid photoacoustic-ultrasound breast imaging systems.Journal of biomedical optics · 2021Article
- MEMS Ultrasound Transducers for Endoscopic Photoacoustic Imaging Applications.Micromachines · 2020Review
- Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.Breast cancer research and treatment · 2020Article
- CEST MRI quantification procedures for breast cancer treatment-related lymphedema therapy evaluation.Magnetic resonance in medicine · 2020Article
- Monte Carlo simulation of light scattering in tissue for the design of skin-like optical devices.Biomedical optics express · 2019Article
- Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers.International journal of nanomedicine · 2017Article
- In vivo molecular imaging of Barrett's esophagus with confocal laser endomicroscopy.Gastroenterology · 2013Article
- Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results.Science translational medicine · 2013Article
- Advancing the translation of optical imaging agents for clinical imaging.Biomedical optics express · 2013Article
- Introduction: feature issue on phantoms for the performance evaluation and validation of optical medical imaging devices.Biomedical optics express · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Medical imaging is an invaluable tool for diagnosis, surgical guidance, and assessment of treatment efficacy. The Network for Translational Research (NTR) for Optical Imaging consists of four research groups working to "bridge the gap" between lab discovery and clinical use of fluorescence- and photoacoustic-based imaging devices used with imaging biomarkers. While the groups are using different modalities, all the groups face similar challenges when attempting to validate these systems for FDA approval and, ultimately, clinical use. Validation steps taken, as well as future needs, are described here. The group hopes to provide translational validation guidance for itself, as well as other researchers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.